Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Avacta Group Plc (Avacta) is clinical stage biopharmaceutical company that develops innovative therapies for the treatment of cancer. The company pipeline products including AVA6000 which treats breast cancer, head and neck cancers and dedifferentiated liposarcoma; AVA6103 treats gastric cancer, triple-negative breast cancer, small cell lung cancer, pancreatic ductal adenocarcinoma; AVA7100 for head and neck squamous cell cancers, non-small cell lung cancer, colorectal cancer; and AVA6207. Its proprietary The Avacta pre|CISION platform is designed to concentrate highly potent warheads in the tumor microenvironment while sparing normal tissues. Avacta is headquartered in London, England, the UK.
Headquarters
United Kingdom
Address
58 Wood Lane, Scale Space, White City Imperial College Campus, London, England, W127RZ
Website
www.avacta.com
Telephone
44 20 39110353
No of Employees
81
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
AVCT (LON)
Revenue (2024)
$148,900
EPS
XYZ
Net Income (2024)
XYZ
26.9%
(2024 vs 2023)
Market Cap*
$420.6M
Net Profit Margin (2024)
XYZ
26.9%
(2024 vs 2023)
* As of and is in US$
Products and Services
| Products | Brands |
|---|---|
| Product: | pre |
| Pipeline | CISION |
| AVA6000 - Breast Cancer, Head and Neck Cancers, Dedifferentiated Liposarcoma | |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In March, the company entered into an agreement to sell its UK-based diagnostics unit, Launch Diagnostics Holdings Limited to Duomed Belgium NV. |
| 2023 | Acquisitions/Mergers/Takeovers | In June, the company acquired Coris BioConcept for US$9.2 million. |
| 2022 | Contracts/Agreements | In October, the company entered into an agreement to acquire Papyrus. |
Competitor Comparison
| Key Parameters | Avacta Group Plc | Smith & Nephew Plc | Deltex Medical Group Plc | GlySure Ltd | Haemair Ltd |
|---|---|---|---|---|---|
| Headquarters | United Kingdom | United Kingdom | United Kingdom | United Kingdom | United Kingdom |
| City | London | Watford | Chichester | Abingdon | Swansea |
| State/Province | England | England | England | England | Wales |
| No. of Employees | 81 | 16,988 | 24 | - | - |
| Entity Type | Public | Public | Private | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Christina Marie Coughlin, MD, PhD | Chief Executive Officer; Director | Executive Board | 2022 | 56 |
| Patrick Vink | Deputy Chairman | Executive Board | 2026 | - |
| Brian Hahn | Secretary; Chief Financial Officer | Senior Management | 2025 | - |
| Karen Harrison | Chief Operating Officer | Senior Management | - | - |
| David Liebowitz, M.D., Ph.D. | Chief Medical Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer